Ombitasvir/paritaprevir/ritonavir 12.5mg/75mg/50mg (Viekirax®)
NHSE clinical commissioning policy statement: Treatment of chronic hepatitis C in patients with cirrhosis
- Traffic LightRed
- BNF5.3.3
- Licensed IndicatorsChronic hepatitis C
- ReferenceAPC Mar 15 APC Sep 15
- Criteria
- ProvisionalNo
Do you want to add this to your CPD record?
Did you find this page helpful?